Critical Therapeutics to Report Fourth-Quarter and Year-End 2007 Financial Results on March 27.LEXINGTON, Mass. -- Critical Therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. , Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CRTX) will conduct a conference call at 5:00 p.m. (ET) on Thursday, March 27, following the release of its fourth-quarter and year-end 2007 financial results. Critical Therapeutics' Senior Vice President and Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. , Trevor Phillips Trevor Phillips OBE (born in London on December 31 1953) is a Black British Labour politician and former political journalist of Guyanese origins. After supporting multiculturalism for many years, Phillips is now one of its most outspoken mainstream critics. , will lead the call, during which management will discuss the Company's fourth-quarter and year-end financial results, recent corporate activities and upcoming milestones. Investors and others are invited to listen live via telephone or the Internet Internet Publicly accessible computer network connecting many smaller networks from around the world. It grew out of a U.S. Defense Department program called ARPANET (Advanced Research Projects Agency Network), established in 1969 with connections between computers at the . What: Critical Therapeutics Fourth Quarter 2007 Financial Results Conference Call When: 5:00 p.m. (ET) Thursday, March 27, 2008 Dial-in: From the U.S. and Canada, dial (877) 407-8037 International callers, dial (201) 689-8037 Webcast: Visit www.crtx.com, select "Investors" and then click on the conference call link. Replay: Visit www.crtx.com, select "Investors" and then "Webcasts & Presentations." About Critical Therapeutics Critical Therapeutics, Inc. is developing and commercializing innovative products for respiratory, inflammatory and critical care diseases. The Company owns worldwide rights to two FDA-approved drugs: ZYFLO CR[TM] (zileuton zileuton /zi·leu·ton/ (zi-loo´ton) an inhibitor of leukotriene formation, used as an antiasthmatic. Zileuton (Zyflo) ) extended-release tablets and ZYFLO[R] (zileuton tablets). Critical Therapeutics is developing products for acute asthma attacks that lead patients to the emergency room and other urgent care settings. The Company also is developing therapies directed toward the body's inflammatory response. Critical Therapeutics is located in Lexington, Mass. For more information, please visit www.crtx.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion